Buradasınız

Anasayfa » Content

Renal Transplant Alıcılarında Serum CRP, SAA ve C5a Düzeylerinin Akut Rejeksiyonun Erken Tanı ve Takibindeki Önemi

Significance of Serum CRP, SAA and C5a Levels in the Diagnosis and Management of Acute Renal Allograft Rejection

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2005

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Interpretation of the significance of SAA, CRP and C5a levels in the early diagnosis and follow-up of acute rejection has been aimed. Thirty-nine patients who underwent renal transplantation at the Çukurova University Transplantation Unit between November 2001 and January 2004 were included in the study. The levels of SAA, CPR and C5a were measured before transplantation and du¬ ring two weeks after transplantation. In 6 of the 39 patients who underwent renal transplantation acute rejection occured. The outcomes indicated that serum SAA and CRP levels increased 1-2 days prior to acute rejection (p<0.001). It can be concluded that the use of serial measurements of serum SAA and CRP levels is a valuable and easy method in the early diagnosis and management of acute allograft rejection.
Bookmark/Search this post with
Abstract (Original Language): 
Renal transplant alıcılarında serum CRP, SAA ve C5a ölçümlerinin akut rejeksiyonun erken teşhis ve takibindeki önemi araştırıldı. Çukurova Üniversitesi Organ Nakli Merkezi'nde, Kasım 2001 ve Ocak 2004 arasında renal transplantasyon yapılan 39 alıcı çalışma grubu, 25 sağlıklı kişi kontrol grubu olarak çalışmaya alındı. Transplant alıcıların SAA, CRP ve C5a düzeyleri transplant öncesi ve transplant sonrası dönemde iki hafta süresince ölçüldü. Otuz dokuz alıcının 6'sında akut allogreft rejeksiyonu gelişti. Rejeksiyon gelişen alıcılarda, SAA ve CRP düzeylerinin, rejeksiyondan 1-2 gün önce yükseldiği ve bunun anlamlı olduğu (p<0.001), C5a değerlerininde ise fark olmadığı saptandı (p>0.05). Renal transplantasyon sonrası, serum CRP ve SAA düzeyleri¬ nin ölçümlerinin, akut rejeksiyon gelişen hastaların erken tanısı ve takibinde rahatlıkla kullanılabilecek, değerli, risksiz ve uygulanması kolay bir yöntem olduğu gürüşündeyiz.
FULL TEXT (PDF): 
PDF icon pdf_tndt_544.pdf
  • 4
171-176
  • Turkish

REFERENCES

References: 

1. Gurley K, Lowry R, Clarce RD. Immune mechanisms in organ allograft rejection: T helper cells, delayed type hypersensitivity and rejection of renal allografts. Transplantation 1983; 36(1): 401-4
2. Oyen O, Wergeland R, Bentdal O, et al. Serial ultrasensitive CRP measurement may be useful in rejection diagnosis after kidney transplantation. Transplant Proc 2001; 33(4): 2481-3.
3. Their M, Ronnholm K, Sairanen H, et al. Serum C-reactive pro¬tein in pediatric kidney and liver transplant patients. Pediatr Transplant 2002; 6(2): 153-60.
4. Reek C, Conrad S, Tenschert W, et al. Do serum C-reactive protein measurements help to discriminate episodes of renal dysfunction in patients after renal transplantation? Clin Chim Acta 2001; 310(1): 57-61.
5. Bruzzane P, Spanga G, Castagneto M, et al. Temporal patterns of C-reactive protein and other acute phase proteins after kid¬ney transplantation. Transplant Proc 1987; 19(5): 3727-30.
6. Fukuda Y, Hoshino S, Tanaka I, et al. Examination of serum
amyloid A protein in kidney transplant patients. Transplant Proc 2000; 32: 1796-8.
7. Fukuda Y, Kanbe M, Sumimoto R, et al. Examination of serum amyloid A and C-reactive protein for monitoring the occurren¬ce of renal-allograft-related complications. Hiroshima J Med Sci
1998; 47(2): 63-7.
8. Liuzzo G, Biasucci LM, Gallimore JR. The prognostic value of C-reactive protein and serum amyloid A protein in severe uns¬table angina. N Engl J Med 1994; 331: 417-424.
9. Sezer S, Akcay A, Ozdemir FN, et al. Post-transplant C-reactive protein monitoring can predict chronic allograft nephropathy.
Clin Transplant 2004; 18(6): 722-5.
10. Thomas F. Müller, Michael Kraus, Christine Neumann. Detec¬tion of renal allograft rejection by complement components C5a and TCC in plasma and urine. J Lab Clin Med 1997; 129(1):
62-71.
11. Müller TF, Neumann CM, Greb C, et al. The anaphylatoxin C5a, a new parameter in the diagnosis of renal allograft rejec¬tion. Tranpl Int 1996; 9(1): 58-62.
12. Maury CP. Comparative study of serum amyloid A protein and C-reactive protein in disease. Clin Sci 1985; 68(2): 233-8.
13. Whicher JT, Chambers RE, Higgrison JJ, et al. Acute phase res¬ponse of serum amyloid A protein and C reactive protein to the common cold and influenza. Clin Pathol 1985, 38(3): 312-6.
14. Maury CP, Teppo A, Eklund B, et al. Serum amyloid A protein: a sensitive indicator of renal allograft rejection in humans.
Transplantation 1983; 36(5): 501-4.
15. Maury CP, Teppo A, Ahonen J, et al. Measurement of serum amyloid A protein concentration as test of renal allograft rejec¬tion in patients with initially non-functioning grafts. Br Med J
(Clin Res Ed) 1984; 288 (6414): 360-1.
16. Hartmann A, Eide TC, Fauchald P, et al. Serum amyloid A pro¬tein is a clinically useful indicator of acute renal allograft rejec¬tion. Nephrol Dial Trasplant 1997; 12(1): 161-6.
17. Casl MT, Bulatovic G, Orlic P, et al. The diagnostic capacity of serum amyloid A protein for early recognition of kidney allog-
raft rejection. Nephrol Dial Trasplant 1995; 10(10): 1901-4.
18. Reek C, Conrad S, Huland H. The role of C-reactive protein in graft dysfunction after renal transplantation. J Urol 1999;
161(5): 1463-6.
19. Jovanovic DB. Clinical importance of determination of serum
amyloid A (Abstract). Srp Arh Celok Lek 2004; 132(7-8): 267-71.
20. Feucht HE, Felber E, Gokel MJ, et al. Vascular deposition of complement split products in kidney allografts with cell-medi¬ated rejection. Clin Exp Immunol 1991; 86: 464-70.
21. Andrews PA, Zhou W, Sacks SH. Tissue synthesis of comp¬lement as an immune regulator. Mol Med Today 1995; 2: 202-7.
22. Solling J. Circulating immune complexes and complement breakdown product C3d in glomerulonephritis and in kidney transplantation. Acta Path Microbiol Immunol Scand Sect C
1984; 92: 213-20.
23. Guo RF, Ward PA. Role of C5a in inflammatory responses. An-
nu Rev Immunol 2005;23:821-52.

Thank you for copying data from http://www.arastirmax.com